We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
Read MoreHide Full Article
For Immediate Release
Chicago, IL – April 11, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: MGP Ingredients Inc. (MGPI - Free Report) , Medifast Inc. (MED - Free Report) , Ubiquiti Networks Inc. , Yield10 Bioscience Inc. (YTEN - Free Report) and Otter Tail Corp. (OTTR - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Global Growth Concerns Resurface: 5 Safe Picks
After a disappointing 2018, U.S. stock markets bounced back in January 2019, leading to impressive gains for each of the three major stock indexes in the first quarter. However, volatility seems to have crept back into Wall Street.
Concerns over slowing global growth have contributed to this uncertainty and dented investors’ confidence to some extent. On Apr 9, both the Dow and the S&P 500 posted their worst session since Mar 22, while the Nasdaq Composite recorded the largest single-day drop since Mar 27.
IMF Lowers Global Growth Forecast
On Apr 9, the International Monetary Fund (IMF) reduced global economic growth forecasts for 2019. This was the third reduction in the last six months. The new growth projection is 3.3% compared with 3.5% projected in January and 3.7% forecast in October. For 2020, global growth is pegged at 3.6%.
The projection for U.S. economic growth was reduced to 2.3% from 2.5%. Eurozone’s growth projection was pushed down to 1.3% from 1.6% while the GDP growth forecast for Canada was decreased to 1.5% from 1.9%. However, China’s economy is estimated to grow 6.3% versus the prior estimate of 6.2%.
Notably, on Mar 20, the Fed lowered the U.S. GDP growth rate to 2.1% in 2019 from 2.3% projected in December. On Mar 4, the Chinese authority pegged the country’s growth rate in the range of 6 - 6.5% for 2019. On Mar 7, the European Central Bank lowered its 2019 growth projection for the Eurozone to 1.1% from its earlier projection of 1.7%.
The IMF cited trade-related conflict, likelihood of a tighter monetary policy by the central bank, especially the Fed, appreciation of U.S. dollar prices and geopolitical concerns such as Brexit and middle-east problems are near-term challenges.
U.S. Trade Tensions Heighten
The year-long trade conflict between the United States and China is yet to resolve. Although significant positive developments have been achieved in this year, a major area of conflict, which deals with protection of U.S. intellectual property, is still under negotiation process. Notably, China is the largest trading partner of the United States commanding 16% of U.S. global trade.
On Apr 8, the U.S. Trade Representative proposed to levy tariffs worth of $11 billion on Eurozone products. An array of products including large commercial aircraft and parts, dairy products and wine will fall under U.S. tariffs.
This is a retaliatory measure to what the Trump administration believes are illegal subsidies that the Eurozone countries provide to Airbus. This will impact sales of U.S. made aircraft. However, the European Union (EU) has strongly objected to White House and threatened to impose retaliatory tariffs.
The U.S. government has already imposed 25% tariffs on imported steel from Eurozone and 10% tariff on imported aluminum. The EU has retaliated with $3 billion of counter tariffs on U.S. exports. Moreover, President Trump has threatened to levy 25% tariffs on EU auto products. Notably, the U.S- EU trading relationship is worth more than $1 trillion per annum.
On Nov 30, the United States, Canada and Mexico had formed a new trade and tariff agreement called United States Mexico Canada Agreement (USMCA) to replace the old North American Free Trade Agreement (NAFTA). However, approval of the USMCA by the U.S. Congress is not certain as majority House Democrats and a key Senate Republican have expressed concerns over the deal. Notably, both Canada and Mexico constitute 30% of U.S. global trade.
Our Picks
At this juncture, investing in defensive sectors such as utilities, telecom and consumer staple will be fruitful. Defensive stocks are generally immune to the vagaries of the economic cycle. That’s because these companies provide basic services like electricity, gas and water, which can never go out of demand. We have narrowed down our search to five stocks with a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
MGP Ingredients Inc.produces and supplies distilled spirits, and specialty wheat proteins and starch food ingredients. The company has an expected earnings growth rate of 20.3% for the current year. The Zacks Consensus Estimate for the current year has improved 6.5% over the last 60 days.
Medifast Inc.manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. The company has an expected earnings growth rate of 41.1% for the current year. The Zacks Consensus Estimate for the current year has improved 11.5% over the last 60 days.
Ubiquiti Networks Inc.develops networking technology for service providers, enterprises, and consumers. The company has an expected earnings growth rate of 26.3% for the current year. The Zacks Consensus Estimate for the current year has improved 13.1% over the last 60 days.
Yield10 Bioscience Inc.engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company has an expected earnings growth rate of 52.2% for the current year. The Zacks Consensus Estimate for the current year has improved 2.3% over the last 60 days.
Otter Tail Corp.engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company has an expected earnings growth rate of 6.8% for the current year. The Zacks Consensus Estimate for the current year has improved 4.8% over the last 60 days.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
For Immediate Release
Chicago, IL – April 11, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: MGP Ingredients Inc. (MGPI - Free Report) , Medifast Inc. (MED - Free Report) , Ubiquiti Networks Inc. , Yield10 Bioscience Inc. (YTEN - Free Report) and Otter Tail Corp. (OTTR - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Global Growth Concerns Resurface: 5 Safe Picks
After a disappointing 2018, U.S. stock markets bounced back in January 2019, leading to impressive gains for each of the three major stock indexes in the first quarter. However, volatility seems to have crept back into Wall Street.
Concerns over slowing global growth have contributed to this uncertainty and dented investors’ confidence to some extent. On Apr 9, both the Dow and the S&P 500 posted their worst session since Mar 22, while the Nasdaq Composite recorded the largest single-day drop since Mar 27.
IMF Lowers Global Growth Forecast
On Apr 9, the International Monetary Fund (IMF) reduced global economic growth forecasts for 2019. This was the third reduction in the last six months. The new growth projection is 3.3% compared with 3.5% projected in January and 3.7% forecast in October. For 2020, global growth is pegged at 3.6%.
The projection for U.S. economic growth was reduced to 2.3% from 2.5%. Eurozone’s growth projection was pushed down to 1.3% from 1.6% while the GDP growth forecast for Canada was decreased to 1.5% from 1.9%. However, China’s economy is estimated to grow 6.3% versus the prior estimate of 6.2%.
Notably, on Mar 20, the Fed lowered the U.S. GDP growth rate to 2.1% in 2019 from 2.3% projected in December. On Mar 4, the Chinese authority pegged the country’s growth rate in the range of 6 - 6.5% for 2019. On Mar 7, the European Central Bank lowered its 2019 growth projection for the Eurozone to 1.1% from its earlier projection of 1.7%.
The IMF cited trade-related conflict, likelihood of a tighter monetary policy by the central bank, especially the Fed, appreciation of U.S. dollar prices and geopolitical concerns such as Brexit and middle-east problems are near-term challenges.
U.S. Trade Tensions Heighten
The year-long trade conflict between the United States and China is yet to resolve. Although significant positive developments have been achieved in this year, a major area of conflict, which deals with protection of U.S. intellectual property, is still under negotiation process. Notably, China is the largest trading partner of the United States commanding 16% of U.S. global trade.
On Apr 8, the U.S. Trade Representative proposed to levy tariffs worth of $11 billion on Eurozone products. An array of products including large commercial aircraft and parts, dairy products and wine will fall under U.S. tariffs.
This is a retaliatory measure to what the Trump administration believes are illegal subsidies that the Eurozone countries provide to Airbus. This will impact sales of U.S. made aircraft. However, the European Union (EU) has strongly objected to White House and threatened to impose retaliatory tariffs.
The U.S. government has already imposed 25% tariffs on imported steel from Eurozone and 10% tariff on imported aluminum. The EU has retaliated with $3 billion of counter tariffs on U.S. exports. Moreover, President Trump has threatened to levy 25% tariffs on EU auto products. Notably, the U.S- EU trading relationship is worth more than $1 trillion per annum.
On Nov 30, the United States, Canada and Mexico had formed a new trade and tariff agreement called United States Mexico Canada Agreement (USMCA) to replace the old North American Free Trade Agreement (NAFTA). However, approval of the USMCA by the U.S. Congress is not certain as majority House Democrats and a key Senate Republican have expressed concerns over the deal. Notably, both Canada and Mexico constitute 30% of U.S. global trade.
Our Picks
At this juncture, investing in defensive sectors such as utilities, telecom and consumer staple will be fruitful. Defensive stocks are generally immune to the vagaries of the economic cycle. That’s because these companies provide basic services like electricity, gas and water, which can never go out of demand. We have narrowed down our search to five stocks with a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
MGP Ingredients Inc.produces and supplies distilled spirits, and specialty wheat proteins and starch food ingredients. The company has an expected earnings growth rate of 20.3% for the current year. The Zacks Consensus Estimate for the current year has improved 6.5% over the last 60 days.
Medifast Inc.manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. The company has an expected earnings growth rate of 41.1% for the current year. The Zacks Consensus Estimate for the current year has improved 11.5% over the last 60 days.
Ubiquiti Networks Inc.develops networking technology for service providers, enterprises, and consumers. The company has an expected earnings growth rate of 26.3% for the current year. The Zacks Consensus Estimate for the current year has improved 13.1% over the last 60 days.
Yield10 Bioscience Inc.engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company has an expected earnings growth rate of 52.2% for the current year. The Zacks Consensus Estimate for the current year has improved 2.3% over the last 60 days.
Otter Tail Corp.engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company has an expected earnings growth rate of 6.8% for the current year. The Zacks Consensus Estimate for the current year has improved 4.8% over the last 60 days.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
See Latest Stocks Today >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.